Publication & Citation Trends
Publications
0 total
Validation of the triple timed up‐and‐go test in Lambert‐Eaton myasthenia OA
Cited by 7
Semantic Scholar
Reply: 3,4-diaminopyridine in LEMS: Concerns regarding presentation of previous studies OA
Cited by 0
Semantic Scholar
3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia OA
Cited by 44
Semantic Scholar
Reply OA
Cited by 1
Semantic Scholar
Novel valosin-containing protein mutations associated with multisystem proteinopathy. OA
Cited by 22
Semantic Scholar
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4‐diaminopyridine
Cited by 28
Semantic Scholar
RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME (LEMS).
Cited by 1
Semantic Scholar
Cognition, Behavior, and Respiratory Function in Amyotrophic Lateral Sclerosis OA
Cited by 15
Semantic Scholar
Amyloidotic Autonomic Failure
Cited by 0
Semantic Scholar
Research Topics
Amyotrophic Lateral Sclerosis Research
(19)
Hereditary Neurological Disorders
(15)
Genetic Neurodegenerative Diseases
(13)
Botulinum Toxin and Related Neurological Disorders
(12)
Neurogenetic and Muscular Disorders Research
(12)
Affiliations
National Institutes of Health
Michael E. DeBakey VA Medical Center
Houghton Mifflin Harcourt (United States)
United States Department of Veterans Affairs
Texas Medical Center